The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation

Human Immunology

Volumn 73, Issue 3, 2012, Pages 248-257

  Luevano, Martha ^a   Daryouzeh, Mehri ^a   Alnabhan, Rehab ^a   Querol, Sergio ^a,b   Khakoo, Salim ^c   Madrigal, Alejandro ^a   Saudemont, Aurore ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BANC DE SANG I TEIXITS   (Spain)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cord blood; Hematopoietic stem cell transplantation; Immunotherapy; Natural killer cells

Indexed keywords

CD56 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CHROMIUM 51; GAMMA INTERFERON; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A;

ARTICLE; CELL MATURATION; CONTROLLED STUDY; DEGRANULATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; INTERFERON PRODUCTION; INTRACELLULAR KILLING; LYMPHOCYTE COUNT; LYMPHOCYTE CULTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD NATURAL KILLER CELL;

ANTIGENS, CD56; ANTIGENS, NEOPLASM; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, CXCR4; RECEPTORS, LYMPHOCYTE HOMING;

EID: 84857114980     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.015     Document Type: Article

References (43)

1. Copelan E.A. Hematopoietic stem-cell transplantation. N Engl J Med 2006, 354:1813-1826.
2. Shlomchik W.D. Graft-versus-host disease. Nat Rev Immunol 2007, 7:340-352.
3. Rocha V., Wagner J.E., Sobocinski K.A., Klein J.P., Zhang M.J., Horowitz M.M., et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 2000, 342:1846-1854.
4. Barker J.N., Wagner J.E. Umbilical cord blood transplantation: current practice and future innovations. Crit Rev Oncol/Hematol 2003, 48:35-43.
5. Kotylo P.K., Baenzinger J., Yoder M.C., Engle W.A., Bolinger C.D. Rapid analysis of lymphocyte subsets in cord blood. Am J Clin Pathol 1990, 93:263-266.
6. Dalle J.H., Menezes J., Wagner E., Blagdon M., Champagne J., Champagne M.A., et al. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res 2005, 57:649-655.
7. Beziat V., Nguyen S., Lapusan S., Hervier B., Dhedin N., Bories D., et al. Fully functional NK cells after unrelated cord blood transplantation. Leukemia 2009, 23:721-728.
8. Verneris M.R., Miller J.S. The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells. Br J Haematol 2009, 147:185-191.
9. Wang Y., Xu H., Zheng X., Wei H., Sun R., Tian Z. High expression of NKG2A/CD94 and low expression of granzyme B are associated with reduced cord blood NK cell activity. Cell Mol Immunol 2007, 4:377-382.
10. Phillips J.H., Hori T., Nagler A., Bhat N., Spits H., Lanier L.L. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins. J Exp Med 1992, 175:1055-1065.
11. Gaddy J., Risdon G., Broxmeyer H.E. Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. J Interferon Cytokine Res 1995, 15:527-536.
12. Tanaka H., Kai S., Yamaguchi M., Misawa M., Fujimori Y., Yamamoto M., et al. Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood. Eur J Haematol 2003, 71:29-38.
13. Bradstock K.F., Luxford C., Grimsley P.G. Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens. Immunol Cell Biol 1993, 71:535-542.
14. - NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. Clin Immunol 2008, 128:46-56.
15. + natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A 2005, 102:2886-2891.
16. +CDC25High T-cells control potentially viremia in blood donors with HCV. J Med Virol 2009, 81:49-59.
17. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol 2001, 22:633-640.
18. Cooper M.A., Fehniger T.A., Turner S.C., Chen K.S., Ghaheri B.A., Ghayur T., et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001, 97:3146-3151.
19. Freud A.G., Caligiuri M.A. Human natural killer cell development. Immunol Rev 2006, 214:56-72.
20. Freud A.G., Yokohama A., Becknell B., Lee M.T., Mao H.C., Ferketich A.K., et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 2006, 203:1033-1043.
21. Grzywacz B., Kataria N., Sikora M., Oostendorp R.A., Dzierzak E.A., Blazar B.R., et al. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood 2006, 108:3824-3833.
22. Brown M.H., Boles K., van der Merwe P.A., Kumar V., Mathew P.A., Barclay A.N. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med 1998, 188:2083-2090.
23. Berlin C., Bargatze R., Campbell J.J., von Andrian U.H., Szabo M.C., Hasslen S.R., et al. Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 1995, 80:413-422.
24. Beider K., Nagler A., Wald O., Franitza S., Dagan-Berger M., Wald H., et al. Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. Blood 2003, 102:1951-1958.
25. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
26. + cells. J Leukoc Biol 2008, 84:1130-1140.
27. Frey M., Packianathan N.B., Fehniger T.A., Ross M.E., Wang W.C., Stewart C.C., et al. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 1998, 161:400-408.
28. Palmer L.A., Sale G.E., Balogun J.I., Li D., Jones D., Molldrem J.J., et al. Chemokine receptor CCR5 mediates alloimmune responses in graft-versus-host disease. Biol Blood Marrow Transplant 2010, 16:311-319.
29. Hamann A., Andrew D.P., Jablonski-Westrich D., Holzmann B., Butcher E.C. Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo. J Immunol 1994, 152:3282-3293.
30. Kellersmann R., Lazarovits A., Grant D., Garcia B., Chan B., Kellersmann A., et al. Monoclonal antibody against beta7 integrins, but not beta7 deficiency, attenuates intestinal allograft rejection in mice. Transplantation 2002, 74:1327-1334.
31. Maghazachi A.A. Role of chemokines in the biology of natural killer cells. Curr Top Microbiol Immunol 2010, 341:37-58.
32. Theilgaard-Mönch K., Raaschou-Jensen K., Palm H., Schjødt K., Heilmann C., Vindeløv L., et al. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant 2001, 28:1073-1082.
33. +56- cells with low lytic activity are possible precursors of mature natural killer cells. Cell Immunol 1997, 180:132-142.
34. Gasser S., Raulet D.H. Activation and self-tolerance of natural killer cells. Immunol Rev 2006, 214:130-142.
35. Joncker N.T., Raulet D.H. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol Rev 2008, 224:85-97.
36. Jonsson A.H., Yokohama W.M. Natural killer cell tolerance licensing and other mechanisms. Adv Immunol 2009, 101:27-79.
37. Elliott J.M., Wahle J.A., Yokoyama W.M. MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment. J Exp Med 2010, 207:2073-2079.
38. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005, 436:709-713.
39. Yokoyama W.M., Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 2006, 214:143-154.
40. Joncker N.T., Shifrin N., Delebecque F., Raulet D.H. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med 2010, 207:2065-2072.
41. Moretta L., Bottino C., Pende D., Mingari M.C., Biassoni R., Moretta A. Human natural killer cells: their origin, receptors and function. Eur J Immunol 2002, 32:1205-1211.
42. Vacca P., Pietra G., Falco M., Romeo E., Bottino C., Bellora F., et al. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood 2006, 108:4078-4085.
43. Qian J.X., Lee S.M., Suen Y., Knoppel E., van de Ven C., Cairo M.S. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 1997, 90:3106-3117.